Texas Southern University (TSU), an historically black university, is legislatively designated as a special purpose institution for urban programming. TSU's mission is to academically prepare and develop diverse, predominantly African American students to enter a dynamic and changing world as upwardly mobile, productive citizens and to contribute to academe with scholarship, research, and outreach programs to the community. TSU has a distinguished history of educating and training large numbers of African Americans to provide competent and culturally sensitive health care to minority communities throughout the city of Houston, the state, the nation, and the world. Building on thriving academic, research, and training infrastructures, TSU is uniquely positioned and capable of producing competent and competitive health professionals and scientists to provide solutions to cardiovascular, cerebrovascular, and pulmonary diseases that cause a disproportionate incidence of morbidity and mortality in the African American population. The recruitment of an established research scientist will help TSU achieve the next level of biomedical research excellence by 1) expanding and strengthening its research capabilities, 2) providing opportunities for structured and supportive faculty development, 3) improving the science curriculum, and 4) providing quality biomedical research experiences for its students. Because of its location, reputation, resources, faculty, and improving research infrastructure, TSU has exceptional potential for training even larger numbers of health professionals to conduct quality biomedical and behavioral research through its academic, research, and training programs. Beneficiaries of these efforts include a core group of talented faculty investigators who have received training support from NHLBI and whose research careers will be enhanced by the proposed initiative. Additional beneficiaries include existing science faculty who desire to develop research capabilities consistent with the university's, NHLBI's, and ORMH's missions, students, and minority communities. A contemporary research infrastructure coupled with faculty possessing strong biomedical research backgrounds will impact positively on all program participants and constituencies. Future generations of scientists will be trained to engage in reducing the disparity in the health status of African Americans in the United States, especially relating to cardiovascular, cerebrovascular, pulmonary, and related diseases and disorders.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
HBCU Research Scientist Award (UH1)
Project #
5UH1HL003674-07
Application #
6799289
Study Section
Special Emphasis Panel (ZHL1-CSR-A (S1))
Program Officer
Paltoo, Dina
Project Start
1996-09-30
Project End
2006-08-31
Budget Start
2004-09-01
Budget End
2006-08-31
Support Year
7
Fiscal Year
2004
Total Cost
$500,000
Indirect Cost
Name
Texas Southern University
Department
Type
Other Domestic Higher Education
DUNS #
050298975
City
Houston
State
TX
Country
United States
Zip Code
77004
Oyagbemi, Ademola Adetokunbo; Omobowale, Temidayo Olutayo; Adedapo, Adeolu Alex et al. (2016) Kolaviron, Biflavonoid Complex from the Seed of Garcinia kola Attenuated Angiotensin II- and Lypopolysaccharide-induced Vascular Smooth Muscle Cell Proliferation and Nitric Oxide Production. Pharmacognosy Res 8:S50-5
Rizvi, Yasmeen Q; Mehta, Chander S; Oyekan, Adebayo (2013) Interactions of PPAR-alpha and adenosine receptors in hypoxia-induced angiogenesis. Vascul Pharmacol 59:144-51
Yousefipour, Zivar; Oyekan, Adebayo; Newaz, Mohammad (2009) Role of G protein-coupled receptor kinase-2 in peroxisome proliferator-activated receptor gamma-mediated modulation of blood pressure and renal vascular reactivity in SHR. Am J Nephrol 30:201-8
Yakubu, Momoh A; Nsaif, Rami H; Oyekan, Adebayo O (2007) peroxisome proliferator-activated receptor alpha activation-mediated regulation of endothelin-1 production via nitric oxide and protein kinase C signaling pathways in piglet cerebral microvascular endothelial cell culture. J Pharmacol Exp Ther 320:774-81
Blanton, Ahmad; Nsaif, Rami; Hercule, Hantz et al. (2006) Nitric oxide/cytochrome P450 interactions in cyclosporin A-induced effects in the rat. J Hypertens 24:1865-72
Williams, Janae; Bogwu, Justin; Oyekan, Adebayo (2006) The role of the RhoA/Rho-kinase signaling pathway in renal vascular reactivity in endothelial nitric oxide synthase null mice. J Hypertens 24:1429-36
Newaz, Mohammad; Yousefipour, Zivar; Oyekan, Adebayo (2006) Role of PPAR-gamma on the pathogenesis and vascular changes in glycerol-induced acute renal failure. Pharmacol Res 54:234-40
Newaz, Mohammad A; Yousefipour, Zivar; Oyekan, Adebayo (2006) Oxidative stress-associated vascular aging is xanthine oxidase-dependent but not NAD(P)H oxidase-dependent. J Cardiovasc Pharmacol 48:88-94
Long, David A; Newaz, Mohammad A; Prabhakar, Sharma S et al. (2005) Loss of nitric oxide and endothelial-derived hyperpolarizing factor-mediated responses in aging. Kidney Int 68:2154-63
Newaz, Mohammad; Blanton, Ahmad; Fidelis, Paul et al. (2005) NAD(P)H oxidase/nitric oxide interactions in peroxisome proliferator activated receptor (PPAR)alpha-mediated cardiovascular effects. Mutat Res 579:163-71

Showing the most recent 10 out of 21 publications